Literature DB >> 11941945

Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy.

Sheung-Tat Fan1.   

Abstract

There has been a dramatic improvement in recent results of hepatectomy for hepatocellular carcinoma in cirrhotic patients. Hospital mortality rates of less than 5% are frequently reported. The improvement is largely a result of better techniques and performance of surgeons in hepatectomy, and reduction in blood loss and transfusion requirement. Better selection of patients is perhaps a more significant contributory factor. Careful identification of risk factors related to the medical condition of the patient, functional reserve of the liver and volume of the remnant liver is essential for the prevention of postoperative liver failure. Indocyanine green clearance test is the most accurate test for assessment of liver function reserve. An indocyanine green retention rate of 14% at 15 minutes is the safety limit for major hepatectomy for cirrhotic patients. A maximum of 60% of the nontumorous liver can be resected safely. Computed tomography is therefore an important assessment parameter. The liver function reserve also reveals the suitability for hepatectomy. Liver enzymes, alanine aminotransferase or aspartate aminotransferase can reflect the hepatic activity, which could be responsible for the impaired liver function. Steatosis is another factor that influences hepatic function reserve. Age is also an important risk factor in hepatectomy because elderly patients may harbor occult heart disease, reduced respiratory and liver function reserves. After recognizing the risk factors, surgeons should eliminate operative morbidity and mortality by making appropriate decisions based on the assessments. In conclusion, preoperative risk assessment involves evaluation of hepatic function reserve, remnant liver volume, liver status, age and the medical condition of the patient. A 0% hospital mortality rate is considered the objective.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941945

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

Review 1.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

3.  A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.

Authors:  Jean C Emond; Benjamin Samstein; John F Renz
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

4.  Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.

Authors:  Yukinori Tanoue; Atsushi Nanashima; Koichi Yano; Yoshirou Fujii; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Makoto Ikenoue; Takashi Wada; Yoichi Mizutani; Toshinori Hirai
Journal:  Nucl Med Commun       Date:  2019-02       Impact factor: 1.690

5.  Donor Indocyanine Green Clearance Test Predicts Graft Quality and Early Graft Prognosis After Liver Transplantation.

Authors:  Yunhua Tang; Ming Han; Maogen Chen; Xiaoping Wang; Fei Ji; Qiang Zhao; Zhiheng Zhang; Weiqiang Ju; Dongping Wang; Zhiyong Guo; Xiaoshun He
Journal:  Dig Dis Sci       Date:  2017-09-20       Impact factor: 3.199

6.  Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis.

Authors:  Masahiko Taniguchi; Atsutaka Okizaki; Kenji Watanabe; Koji Imai; Koichiro Uchida; Takahiro Einama; Noriyuki Shuke; Naoyuki Miyokawa; Hiroyuki Furukawa
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.

Authors:  Yi-Ming Li; Fan Lv; Xin Xu; Hong Ji; Wen-Tao Gao; Tuan-Jie Lei; Gui-Bing Ren; Zhi-Lan Bai; Qiang Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization.

Authors:  Stéphane Zalinski; Olivier Scatton; Bruto Randone; Olivier Vignaux; Bertrand Dousset
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis.

Authors:  Chunping Jiang; Zhongxia Wang; Qingxiang Xu; Xingyu Wu; Yitao Ding
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.